Tag: healthcare
Rivaroxaban / Xarelto compensation settlements have landed in the U.S., to the tune of $775m for around 25,000 cases being pursued.
The money is to be paid out by both Bayer AG and Johnson & Johnson as the co-creators of the drug. They strenuously deny any wrongdoing, and maintain that the drug is safe for use. However, the settlements have been agreed without any admission of liability.
The blood-thinning medication that’s used for stroke patients has been at the centre of concerns for quite some time. We’re representing patients who have suffered side-effects from using the drug as part of claims for personal injury compensation. Although the settlement is for the U.S. only, this is a positive step in the global fight for justice.
Read More “Xarelto compensation settlements for 25,000 cases”
Like all drugs, there can be inherent complications. However, there could be more sinister reasons behind certain valsartan side effects people may suffer from.
There’s been a huge Europe-wide recall of the blood pressure drug last year, which we covered last year. This stems from a potential contamination issue in the manufacturing process. As a result, valsartan that’s supplied by Actavis Group PTC (now Accord) and Dexcel Pharma Ltd is now subject to a recall.
The potential contamination issue could be incredibly serous for anyone that’s affected by it. In America, there are already class actions and group cases for people who have taken the drug. Our lawyers want to hear from anyone in the UK who has suffered problems.
In a bid to save some £265m a year, there are set to be free prescription changes to stamp out abuse of the system.
The aim of the changes are to tackle fraudulent free prescriptions that could be wasting millions in valuable resources. From patients not entitled to free prescriptions, to some pharmacists and dentists receiving payments for phantom procedures, it’s an issue that needs resolving.
As the NHS continues to struggle with underfunding, a lack of resources and staff shortages, we can’t have any avoidable waste in the system.
We welcome the move for a crackdown on hospital staff bullying incidents, as alarming figures have revealed the extent of bullying within the NHS.
At a time when NHS funding is already a problem, and the economy remains in an uncertain position because of Brexit, we need an efficient public health service. It’s therefore incredibly concerning to hear about alarming statistics over the extent of hospital staff bullying incidents that are going on.
A crackdown is now set to come into effect where hospital bosses will be held accountable – and even sacked – for failing to deal with bullying in the NHS.
Read More “Crackdown on hospital staff bullying incidents a welcome move”
It’s understood that the HPV vaccine reduces cervical cancer, with a decrease of 86% seen in women aged between 16 to 21.
The recent government reports states that vaccinations to defend against the Human Papilloma Virus (HPV) 16 and 18 infections is working. These infections are known to cause the majority of cervical cancer cases.
The information published over the summer in the Journal of Infectious Diseases is welcome news. The data suggest that the HPV vaccination programme will lead to significant reductions in cervical cancer cases arising in the future.
NHS patients are increasingly being denied hip and knee replacements as a result of funding issues, leaving people at risk of complications and mobility problems.
According to a British Medical Journal study, patients are being denied hip and knee replacements more and more, with refusals increasing by 45% when compared to the previous year.
These restrictions on procedures are a damning reflection of the continuing NHS funding problems that are only going to leave patients more vulnerable to complications and prolonged mobility problems, which in turn could see a rise in cases of negligence.
Last year’s investigation into the tragic Shropshire baby deaths is to be widened as the number of cases has increased from 23 to over 40.
The investigation that was launched last year into the quality of care at a Shrewsbury and Telford NHS Trust maternity unit has been looking into a lack of staff and a lack of a learning couture to prevent incidents, with a number of the Shropshire baby deaths cases being linked to negligence.
Infant deaths, maternal deaths and brain injuries are among the problems that have been linked to poor quality of care within the Trust.
It’s fair to say that the line between due diligence and potential medical negligence is thin. We all know that the NHS is stretched, and services like GPs and A&E Departments must remain efficient and well-funded.
It’s therefore understandable that NHS campaigns nowadays sometimes try and persuade people to only use NHS services where it’s absolutely necessary. In days gone by, doctors may have frowned upon patients Googling their symptoms and jumping to irrational conclusions, but in today’s increasingly digital age, patients are actually encouraged to look online before they use NHS time.
But, the line between this is worryingly thin.
Read More “The line between due diligence and medical negligence is thin”
Missed diagnosis claims, and claims where patients are misdiagnosed, are unfortunately common. One of the biggest problems with such incidents is where the misdiagnosis or missed diagnosis is for something as serious as cancer, where the window of opportunity for cancer care or treatment to start can be very slim.
Unfortunately, in many cancer misdiagnosis or missed cancer diagnosis cases, it’s too late for the victim by the time the error is recognised.
Because of this, some say that good quality cancer care should be introduced as law in the UK. But, will it help?
Read More “Should good standards of cancer care be made law?”